Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens requires 3 DNA injections. Results of the EV03/ANRS Vac20 Phase I/II Trial

Levy, Y. and Ellefsen, K. and Stoeehr, W. and Bart, P. and Lelievre, J. and Launay, O. and Wolf, H. and Weber, J. and Chene, G. and Pantaleo, G. (2010) Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens requires 3 DNA injections. Results of the EV03/ANRS Vac20 Phase I/II Trial. AIDS RESEARCH AND HUMAN RETROVIRUSES, 26 (10). A10. ISSN 0889-2229

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Depositing User: Petra Gürster
Date Deposited: 21 Apr 2020 05:55
Last Modified: 21 Apr 2020 05:55
URI: https://pred.uni-regensburg.de/id/eprint/24031

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.